It is able to inhibit renal angiotensin-II-induced cardiac hypertrophy and fibrosis by manipulating transforming growth factor beta (TGF-β) signaling (28) or by altering the activity of the renal angiotensin system. The gene discussed is TGFB1; the disease is cardiac hypertrophy.